COMP <GO>
CLX vs V // ENTERPRISE SCALE & MARKET CAP
Clorox Company (NYSE) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: CLX 5
— V 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: V
LAST: $88.67 (+2.11%) • MKT CAP: $10.72B
market-cap
$10.72B
LAST: $410.54 (+2.48%) • MKT CAP: $733.53B
market-cap
$733.53B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLX VS. V)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLX | V | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.20% | 32.30% | +4.90 | CLX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.9x | 28.9x | -18.00 | CLX | /valuation <GO> |
| Free Cash Flow Yield | 7.10% | 2.90% | +4.20 | CLX | /fcf-yield <GO> |
| Operating Margin | 14.20% | 60.00% | -45.80 | V | /operating-margins <GO> |
| Net Profit Margin | 11.60% | 50.10% | -38.50 | V | /net-margins <GO> |
| Revenue Growth (YoY) | 0.20% | 11.30% | -11.10 | V | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.61% | 0.63% | +4.98 | CLX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 9.09 | -6.16 | V | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | V | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 65.6 | -10.00 | V | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 1.06 | -0.13 | V | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.1x | 34.0x | -21.90 | CLX | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $10.72B | $733.53B | -$722.81B | V | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLX REV | V REV | CLX GROSS % | V GROSS % | CLX FCF | V FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.10B | $40.00B | 45.2% | — | $761.0M | $21.26B |
| FY 2024 | $7.09B | $35.93B | 43.0% | — | $483.0M | $18.33B |
| FY 2023 | $7.39B | $32.65B | — | — | $825.5M | $19.29B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLX // BETA 0.93
V // BETA 1.06